IPHA Projected Dividend Yield
ADS (Sponsored)/Innate Pharma SA ( NASDAQ : IPHA )Innate Pharma SA is a France-based biopharmaceutical company that develops drugs for treatment of cancer and inflammatory diseases. Co. identifies and characterizes drug candidates, selects indications, and manages the pre-clinical and clinical development of products. Innate Pharma primarily focuses on the development of new therapeutic solutions and monoclonal antibodies for the treatment of cancer, as well as for the treatment of infectious diseases and chronic inflammatory pathologies. Co. develops two categories of immunotherapies: immuno-modulators and cytotoxic antibodies. 21 YEAR PERFORMANCE RESULTS |
IPHA Dividend History Detail IPHA Dividend News IPHA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |